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Abstract 
Ingestible electronics have revolutionized the standard of care for a variety of health conditions. 
Extending the capacity and safety of these devices, and reducing the costs of powering them, could 
enable broad deployment of prolonged monitoring systems for patients. Although previous 
biocompatible power harvesting systems for in vivo use have demonstrated short (minute-long) bursts 
of power from the stomach, little is known about the capacity to power electronics in the longer term 
and throughout the gastrointestinal tract. Here, we report the design and operation of an energy-
harvesting galvanic cell for continuous in vivo temperature sensing and wireless communication. The 
device delivered an average power of 0.23 µW per mm2 of electrode area for an average of 6.1 days of 
temperature measurements in the gastrointestinal tract of pigs. This power-harvesting cell has the 
capacity to provide power for prolonged periods of time to the next generation of ingestible electronic 
devices located in the gastrointestinal tract. 
 
  
 5 
Thanks to recent advances in ingestible electronics, it is now possible to perform video capture1, 
electronically-controlled drug release2, pH, temperature, and pressure recording3, and heart rate and 
respiration monitoring4, all from within electronic pill-like capsules placed in the gastrointestinal (GI) 
tract. Recent progress in energy harvesting and wireless power transfer is offering new options to 
power these devices, but many are not well suited to ingestible capsules.  For example, traditional 
harvesting sources such as thermal5, and vibration6 energy harvesting are complicated by the lack of 
thermal gradients in the stomach and challenges in obtaining mechanical coupling to motion sources.  
Wireless power-transfer via near-field7 or mid-field8 coupling is also challenging in this case, due to the 
unconstrained position and orientation of the capsule.  Hence, there is still a strong reliance on primary 
cell batteries for ingestible electronics.  Hence, most current ingestible electronics still rely on primary 
cell batteries, many of which require toxic materials, have limited shelf life due to self-discharge and 
can cause mucosal injury9. There is therefore a need to explore alternative sources, particularly as the 
circuits scale to lower average power, to enable their use in a practical system. 
A few key trends have led to our work.  For one, the average power demands of 
Complementary Metal-Oxide-Semiconductor (CMOS) technology have been scaling into the nanowatt 
(nW) level thanks to advanced design techniques and technology improvements10–12, enabling a wider 
array of harvesters. Next, advances in material design and packaging have demonstrated fully passive 
gastric devices that are small enough to be swallowed, but then unfold after ingestion to remain long 
term, up to 7 days in the stomach for ultra-long drug delivery13.  Such devices could one day provide an 
ingestible non-invasive platform for active wireless electronic sensors that perform long term in vivo 
vital signs monitoring.  Finally, interest in bio-compatible galvanic cells is rising, with a focus on (1) 
transient electronics that fully disappear at the end of their tasks14, (2) electrolytes that are supplied on 
demand to extend the shelf life of the cell15, (3) material selection for fully biocompatible and 
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biodegradable cells14–17 and recently, (4) edible gastric-Mg-Cu cells, which can power near-field 
communication of medication compliance information to a body-worn patch for up to a few minutes18. 
Additional support for the potential of long-term harvesting is provided by two in vitro studies on cells 
in synthetic gastric-fluid- like electrolytes, which demonstrated measurements lasting a number of 
hours19,20. 
This has led us to investigate the practical use of a biocompatible galvanic cell for powering a 
wireless sensor node in the GI tract. Here, we report an energy-harvesting system with temperature 
sensing and wireless communication, evaluated in a porcine model. We demonstrate a fully 
autonomous sensor system, created from commercial semiconductor parts, and powered solely by the 
cell and capable of providing central temperature measurements. The device can also use the harvested 
power to activate drug release via electrochemical dissolution of a gold membrane. 
Results 
Basic principle and initial characterization 
The bio-galvanic cell characterized in this work consists of a redox couple formed by a 
dissolving metallic anode that undergoes galvanic oxidation and an inert cathode that returns electrons 
to the solution.  In our case, the gastric or intestinal fluids of the surrounding environment form the 
electrolyte. The final performance of the cell is a strong function of environmental conditions that 
change significantly during normal gastrointestinal routines. For example, the pH, chemical 
composition, and heterogeneity of the stomach contents21 vary considerably throughout the day. Hence 
there is a need to obtain the performance of the cell directly by in vivo measurement characterization. 
As previous studies have noted14,22, the cathodic reaction proceeds with either hydrogen gas evolution 
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or by the reduction of dissolved oxygen gas depending on the pH of the solution, and is usually limited 
by mass-transport conditions. The relevant cathodic reactions are given by: 
2 H+   +   2 e−    ↔    H2  (1) 
O2  + 2H2O + 4e−   ↔    4OH− (2) 
A number of materials have been proposed as dissolving anodes, most prominently, 
magnesium18,23 and zinc15,19,20, which are noted for their dietary value24, low cost, ease of 
manufacturability, and their relatively low position in the electrochemical series25. The reaction at the 
anode is given by:  
X       ↔     Xn+   +   n e−     (3) 
where X = Mg or Zn. The cathode, which sends electrons back into the solution, was created from pure 
copper metal26.  
Given prior successes in utilizing magnesium, which has a higher reduction potential, for in 
vivo power generation18, we first considered magnesium anodes for our initial in vivo characterization 
evaluating the impact of electrode size.  In Figure 1 (a)-(d), we characterized a Mg-Cu electrode system 
in a porcine model using small square electrodes of differing areas, mounted on the tip of an endoscope 
as shown in Fig. 1(a) (see Methods).  The current density was stepped in fixed increments resulting in 
the voltage and power densities shown in Fig 1(b). The resulting average peak power density across all 
sizes shown in Fig 1(c) was 2.48 µW/mm2 in the stomach (0.97 µW/mm2 in the duodenum), and the 
average observed cell voltage in Fig 1(d) was 0.23 V. Consistent with the low observed cell voltage, we 
also noted a large amount of corrosion on the magnesium electrodes, suggesting that the lifetime of a 
magnesium-based prototype would not exceed 24 h, thereby making week-long wireless measurements 
unfeasible. 
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Motivated by the observations of corrosion and given the intention to evaluate extended gastric 
residence of these electrodes, we performed extended in vitro studies of electrode longevity (see 
Methods).  With the configuration shown in Fig 1(e), we compared Mg and Zn anodes in side-by-side 
measurements using a load-sweep methodology (50 kΩ down to 150 Ω in 255 steps). Fig 1(f) shows 
the maximum power observed in each load resistance sweep.  The Mg anode gave 1.3× higher cell 
voltage and 6× higher peak power density, but the Zn anode lasted much longer (more than 23×), 
suggesting Zn for longer term use. The combination of the experiments presented in Figure 1 allowed 
us to proceed to the design of a zinc-based measurement capsule to enable evaluation of the power 
parameters via a stand-alone device in vivo.  
 
Characterization in the stomach environment 
We created a measurement capsule (Figure 2, and Methods) to obtain detailed measurements of 
the performance of the Zn-Cu cell in a porcine stomach and transmit the results to a nearby basestation.  
The design was fully self-sufficient and wireless to avoid a tether to the outside that could reduce the 
practical measurement duration or impact the comfort or normal routines of the animal.  A 
conventional coin-cell battery powered the capsule in order to avoid loading the electrodes with the 
demands of the circuitry during measurement, allowing a precise characterization of the cell with a 
separate controllable load. 
The capsule was created using all commercial low-cost semiconductor parts (Fig. 2 a and b) and 
consisted of: (1) an 8-bit digitally controlled potentiometer27 to set the load resistance of the cell, and 
(2) a microcontroller system-on-chip28 and its associated peripherals, which contained (i) a 10-bit 
analog-to-digital converter (ADC) that measured the electrode voltage, (ii) a temperature sensor, (iii) a 
wireless transmitter, and (iv) a processor that ran software code to control all of the functions. 
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To characterize the cell, the software was programmed sweep the load resistance through all 
256 available codes (50 kΩ down to 150 Ω in 255 linear steps), taking voltage measurements at each 
point.  Each step was held for 2 s, and at the end of a sweep, the resistor was reset to 50 kΩ and held 
for a further 64 s for the electrode voltage to re-equilibrate to the light-load condition before starting 
the next measurement (full measurement time: 576 s per sweep).  The data, which included electrode 
voltages at each of the 256 resistor-codes, and the temperature sensor measurements, were transmitted 
as a Frequency-Shift-Keying-modulated, +10 dBm, 920 MHz wireless signal, to a commercial 
basestation receiver, mounted about 2 m away (resistance sweep methodology flow diagram and 
example measured waveforms illustrated in Supplementary Fig. 1 and 2 respectively).  We also 
characterized the Zn-Cu cell and measurement electronics in synthetic gastric fluid (SGF) in vitro prior 
to the animal experiments (data shown in Supplementary Fig. 3). 
The measurement capsule was initially deployed in five animals with the results summarized in 
Fig. 2(d)-(i) and full data shown in Supplementary Fig. 4 and 5 (see Methods for experimental details).  
Due to the recognized slow motility of the porcine GI tract29,30 and the size of the capsule, the devices 
were retained in the animal for 7 days to 10 days without additional design considerations. During this 
time, the data were collected as the animal performed its normal daily routines.  The traces in Fig. 2(d)-
(f) correspond to an example device, and show the electrode voltage measured at the point of maximum 
power density for each load resistance sweep (one sample every 576 s), as well as the associated peak 
power density level, and the temperature recorded by the temperature sensor. Figs. 2(h) and 2(i) give 
the statistics of the measured peak power and optimum source voltage. Across all five stomach-
deployed capsules, the mean time for which power was available, the mean peak power Pmax, and mean 
voltage at Pmax were 5.0 days, 1.14 µW/mm2 and 0.149 V respectively.  There was a large amount of 
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variation in the transit time of the devices, which was anticipated and consistent with prior observations 
of the porcine GI tract29–31.  
Interestingly, by correlating the anatomic location of the capsule determined through serial x-
rays we demonstrated that the peak power drops significantly after passage through the pylorus to the 
small intestine. The combination of Figs. 2(e) and 2(g) shows an example of this correlation.  To 
confirm this observation, we deployed 3 devices directly into the small intestine and tracked their 
passage through the colon until exit. The three devices showed an average of 13.2 nW/mm2 of peak 
power density and the power remained present, between 1 to 100 nW/mm2, throughout the passage 
time until exit (see Supplementary Fig. 4). 
 
Harnessing power in vivo for sensing, communication, and drug delivery 
To demonstrate the utility of the energy obtained, we created a second capsule powered entirely 
by the Zn-Cu cell (see Figure 3, and Methods).  This harvested power was used for all functions of the 
capsule, which included temperature measurement, software control, and wireless transmission to a 
basestation located 2 m away.  In this design (Fig. 3a) we used a commercial energy harvesting boost-
converter integrated circuit (IC)32, which took energy directly from the Zn-Cu cell at low voltage (0.1 
to 0.2 V) and boosted it onto a temporary storage capacitor at a higher voltage (between 2.2 and 3.3 V) 
for use by the circuits. The encapsulated sensor device prepared for deployment is shown in Fig 3(b). 
When the input source is applied, the boost converter IC pulls energy from the input voltage Vin 
and transitions through a startup region.  Once the startup is complete, the main higher-efficiency boost 
converter is activated and sets the OK signal, which then powers the microcontroller through a switch.  
From here the microcontroller transmits packets containing temperature measurement data at a variable 
rate depending on the input power.  Fig. 3(c) shows an example of steady state operation of the capsule, 
 11 
where the storage capacitor is slowly charged until enough energy is available for packet transmission. 
The system regulates the rate by periodically sampling the supply voltage VDD to determine whether to 
send a packet or wait for more energy to be harvested. If the sampled voltage is below 3.0 V, the 
system remains in a low-energy sleep mode for 4 s before attempting to sample again.  If the voltage is 
above 3.0 V, the system transmits a packet and then returns to periodically sampling the voltage 
(initially 0.5 s after the packet, and then again every 4 s) to determine when to transmit the next packet.  
Further details on the capsule design and operation are provided in Supplementary Figs. 6, 7, and 8. 
Since packet transmission is the dominant energy consumer, we used the number of transmitted 
packets in a given window length ("#$%&'#) to estimate the overall amount of energy delivered to the 
load. Each packet is 176 bits long including preamble and headers and is transmitted at 50 kbps, 
resulting in a 3.5 ms packet transmitted at +10 dBm. Prior to the experiments, a laboratory source-
meter was used to characterize the energy consumed by the capsule in transmitting each packet as a 
function of the VDD, 	)*+, = .(011).  Then during the in vivo experiment, the number of packets 
transmitted during a given interval was used to determine the average power (3454,789)	delivered to the 
load using: 
3454,789 = 1"#$%&'# )*+,(011 ; )7<<	=  (4) 
where m represents a packet and Σ is the sum over all the packets transmitted within "#$%&'#. 011 ;  is the measured system VDD at the beginning of each packet transmission – information that 
was transmitted along with the temperature measurement data. To obtain an accurate packet count 
despite the possibility of dropped packets, we also transmit an internally generated packet count to the 
basestation along with the other measurements.  
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The system was deployed in 3 animals and the results are summarized in Fig. 3(d) (full 
measurements in Supplementary Fig. 9). Fig 3(e) shows the power delivered from the cell to the load 
using eqn. (3), with "#$%&'# = 1 h.  Fig 3(f) shows the measured temperature sensor data, and Fig 3(g) 
shows the RF signal strength seen by the receiving basestation for each packet.  Of note was that 
temperature readings below the expected core or central temperature were observed to coincide with 
daytime hours and times around feeding (Fig. 3f), probably representing transient temperature 
decrement associated with ingestion of foods and liquids. The disconnected regions in the figures 
represent periods for which electrical power was not sufficient to send wireless packets, for example, 
due to variations in both the fluidic environment of the stomach and the position of the capsule within 
it.  On average, packets were received in 91% of the 1 h time slots during the three experiments.  
Across all of the experiments, the devices operated for a mean of 6.1 days, delivering an average power 
of 0.23 µW per mm2 of electrode area to the load, and transmitting packets with temperature 
measurements every 12 seconds. 
To further demonstrate the utility of the energy harvested by the system, we designed and 
fabricated a device for drug release that can be triggered with the harvested energy, as shown in Fig 
3(h), and tested this device in vitro with physiologic gastric fluid (See Methods for the details of device 
fabrication). The device, as shown in Fig 3(i), encapsulates a model drug (in this case, methylene blue) 
in a PMMA reservoir (2 mm × 1 mm × 1.5 mm) that is sealed with a 300 nm thick gold membrane. The 
release is achieved via electrochemical dissolution of the membrane, as demonstrated previously by 
Santini et. al33. The gold membrane, which is otherwise inert in the gastric environment, can be 
chemically corroded when the potential is raised (+1.04 V with respect to Saturated Calomel Electrode) 
to allow formation of water-soluble chloro-gold complexes34. Our results show that the device remains 
intact when it is connected to the system ground (shorted to the zinc electrode) in physiologic gastric 
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fluid (See Methods for experimental details). Upon activation via the application of discharge of 
voltage from 2.0 to 2.3 V with respect to zinc system ground, the corrosion of the gold weakens the 
membrane integrity, causing crack formation that is visible at t = 155 minutes (blue arrow, shown in 
the middle inset of Fig. 3j), and ultimately the visible release of the contents (indicated with red arrow 
at the right inset of Fig. 3j.) through the corroded membrane. The voltage profile plotted in Fig 3(k) 
shows the discharge characteristics that gradually activate the release.  The initial shallow ramp from 
3.15 V to 2.95 V represents the microcontroller boot-up followed by temperature measurement. The 
steep drop from 2.95 V to 2.3 V represents the packet transmission, and the more slow discharge from 
2.3 V to 2.0 V represents charges delivered to the gold electrode. With the 220 µF storage capacitance, 
this represents 66 µC of charge delivered to the electrode per pulse.  The pulse ends when the boost 
converter toggles the OK signal to low (due the storage voltage declining below the threshold), which 
deactivates the microcontroller and release electrode switch, and allows the storage capacitor to begin 
charging in preparation for the next cycle.  The average pulse interval during the experiment was 11.9s, 
and charge delivery rate was 5.5 µC/s.  For the designed size of 2 mm x 1 mm active gold area (with 
300 nm thickness), the total theoretical charge necessary to completely dissolve the electrode was 17.0 
mC, and hence an ideal dissolution time of 51 min. In gastric fluid, it is expected that side reactions can 
occur on the electrode surface resulting in a longer release time, hence the observed time of 155 min.  
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Discussion 
Ingestible electronics have an expanding role in the evaluation of patients35.  The potential of 
applying electronics or electrical signals for treatment is being explored36 and the potential for long 
term monitoring and treatment is being realized through the development of systems with the capacity 
for safe extended gastrointestinal residence13,37. Energy alternatives for GI systems are needed to 
enable broad applicability, especially given size and biocompatibility constraints coupled with the 
potential need for long-term power sources and low cost systems. 
Here we report the in vivo characterization of a galvanic cell composed of inexpensive 
biocompatible materials, which are activated by GI fluid.  We have demonstrated energy harvesting 
from the cell for up to 6 days (average power 0.23 µW/mm2) and using this energy we have developed 
a self-powered device with the capacity for central temperature measurement and wireless transmission 
from within a large animal model.  The combining of the cell with a boost converter in the energy 
harvesting IC allowed the system to power these more complex electronics, even as the cell voltage and 
power level varied during the experiments. 
The device we have fabricated could be rapidly implemented for the evaluation of core body 
temperature and for the evaluation of GI transit time given the differential temperature between the 
body and the external environment. A recent study evaluating data collected from 8682 patients found 
that peripheral temperature readings did not have acceptable clinical accuracy to guide clinical 
decisions38. Hence, continuous automated central temperature measurements via a wireless ingestible 
system may provide significant clinical benefit. We have also demonstrated, via a custom designed 
drug release device, that such an energy harvesting method could be used to activate drug delivery via a 
gold membrane corrosion mechanism. This proof of concept could ultimately allow the incorporation 
drug delivery in the ingestible electronic capsule. 
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  Furthermore, we have characterized and demonstrated the capacity for harvesting from across 
the GI tract including stomach, small intestine and colon.  Interestingly, the available power density 
ranged between a few µW/mm2 down to a few nW/mm2 across the GI tract. The reduced power in the 
intestine could potentially be explained by anatomical variation between it and the stomach -- diffusion 
could be impaired by close contact with the intestinal walls.  Further development will be required to 
delineate the exact causes and could lead to an improved design.  In the meantime, these observations 
may guide future development of gastrointestinal resident electronic power harvesting systems 
according to their targeted anatomic location. For example, there may be a need for greater storage 
capability to carry energy from the stomach, or depending on the application, it may be necessary to 
support even lower power modes.  
Our electrode area in this study was limited by the availability of a nanowatt-level commercial 
harvester.  Nevertheless, the total elemental zinc present in our largest tested electrode (30 mm x 3.0 
mm x 0.25 mm) was 161 mg.  Assuming extreme case of full dissolution across the six-day experiment, 
the average zinc ion deposit rate for this electrode would be 27 mg/day.  This amount is below the US 
Food and Nutrition Board recommended upper limit UL = 40 mg/day24, and in line with levels found in 
over-the-counter zinc supplements (15, 30, and 50 mg/day dosings are commonly available).  Looking 
ahead, we would expect that a custom designed system would be able to target much lower power 
levels and hence integrate smaller electrodes and less zinc deposition than we have tested here. 
Research in ultra-low-power electronics continues to push the boundaries of the average power 
consumption, and already provides a range of options for circuits that could be adapted for use in GI 
applications at the nanowatt level. Examples include energy harvesters (for < 10 nW available power10–
12), ADCs and signal acquisition circuits (< 10 nW39,40), far field wireless transmitters (< 1 nW 
standby41), and mm-scale sensor nodes with sensing and processing (< nW standby42). Such systems 
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could allow the electrode dimensions to scale to just a millimetre or two in width and length, and could 
enable broad applications for extended power harvesting from alternative cells for long term 
monitoring of vital signs4 and other parameters in the GI tract, especially with the introduction of 
devices that are deployed endoscopically43 or self-administered13 and have the capacity to reside in the 
gastric cavity for prolonged periods of time.  
Though sufficient for our animal studies, one limitation is the size of the capsule.  Without a 
clear picture of the expected voltage and power levels in vivo at the outset, achieving further 
miniaturization as part of this study would have been challenging.  Given our measured results, and 
with further engineering development, for example, to create a custom single-chip Application Specific 
Integrated Circuit (ASIC)  and to apply enhanced packaging techniques like component stacking, the 
design could potentially be miniaturized by 3 to 5× as compared to the volume of the currently 
presented hardware.  In addition, future work should strive to match animal behavior information, such 
as feeding and motion data, with the measured power level and observed physiologic signals in order to 
better understand the sources of variations observed here. 
One further limitation is the physical design of the electrochemical cell.  Our focus was on 
powering robust in vivo measurements over longer periods of time compared to previously reported 
cells. However, future work should include efforts to improve the voltage and power of the cell; for 
example, by integrating membranes to improve proton exchange20 while controlling corrosion of the 
electrodes44. In addition, further improving the efficiency of low-voltage boost converters at ultra-low 
power levels will facilitate demonstration with smaller electrode areas (approaching 1 mm x 1 mm), or 
allow energy harvesting across the entire GI tract.  Another important direction of future research will 
be the development of systems that can be safely retained in the GI tract over long periods, thereby 
enabling self-powered monitoring on the order of weeks, months or even years following a single 
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ingestion. This work should focus on solving material-, packaging-, and interface-related challenges in 
order to design a capsule for eventual human trials. 
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Methods 
Magnesium, zinc and copper electrode fabrication and attachment. All electrodes were created 
from pure metal foils (Alfa Aesar, 0.25 mm thick) and cut to the specified length and width dimensions 
to within ± 10%.  Attachment of the zinc and copper electrodes to wires or to the PCBs was performed 
with standard solder and flux, whereas magnesium, which is not solderable, was attached with 2-part 
silver conductive epoxy (8331, MG Chemicals).   
 
In vivo characterization of magnesium-copper system.  Electrodes (with attached wires) were fixed 
via thermoplastic adhesive to opposite sides of a 3D-printed post (30 mm long, 3.8 mm diameter) for 
easy mounting on an endoscope for guidance into the stomach and duodenum.  The electrodes were 
connected by a ~3m long cable which passed through the lumen of the endoscope to a Keithley 6430 
source-meter, which executed the specified current steps and voltage measurements from outside the 
animal. 
 
Electrode longevity comparison. Electrode anode and cathode (with attached wires) were placed side-
by-side (3 mm separation) on a polystyrene support and fixed using 2-part epoxy (20845, Devcon), 
with 10 mm electrode length exposed.  The electrode pairs were submerged in a pH 4 buffer solution 
(33643, Fluka Analytical) and measured using the same electronics as the characterization capsule, 
described below. 
 
Characterization and demonstration capsule fabrication: The PCBs for the capsules were 4-layer 
FR4, with 35-µm copper metallization. The electrodes were soldered onto the PCB for protrusion 
outside the encapsulation. Encapsulation was performed as a 2-step process. Prior to 
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polydimethylsiloxane (PDMS) moulding, the boards were fully coated in 2-part epoxy (1-2 mm thick) 
to act as sealant against moisture and prevent fluid from entering the device via the protruding 
electrodes. The outer layer was PDMS (Sylgard 184, Dow Corning), selected for biocompatibility with 
the stomach environment and moulded into a capsule shape to facilitate passage through the GI tract.  
The electrodes protruded through the back of the encapsulated device and were bent around towards 
the front and secured to the outer layer of the PDMS with 2-part epoxy (20845, Devcon). 
 
In vivo characterization.  All procedures were conducted in accordance with the protocols approved 
by the Massachusetts Institute of Technology Committee on Animal Care.  In vivo porcine studies were 
performed in female Yorkshire pigs aged between 4 and 8 months and weighing approximately 45-
50 kg.  The porcine model was specifically selected given prior observations noting slower transit time 
and thereby providing the capacity for extended residence of a macroscopic device in the GI tract29,30.  
Animal sample size was guided by prior work demonstrating proof-of-concept studies with 
gastrointestinal drug delivery and sensor systems4,13,45. In vivo experiments were not blinded or 
randomized. Prior to endoscopy or administration of the prototypes the animals were placed on a liquid 
diet for 48 hours.  The animals were fasted overnight immediately prior to the procedure.  On the day 
of the procedure for the endoscopic characterization studies the animals received induction of 
anesthesia with intramuscular injections of Telazol (tiletamine/zolazepam) 5 mg/kg, xylazine 2 mg/kg, 
and atropine (0.04 mg/kg), the pigs were intubated and maintained on inhaled isoflurane 1-3%.  For the 
deployment of the capsule prototypes the animals were sedated via intramuscular injections of the 
above agents.  The esophagus was intubated and an esophageal overtube placed (US Endoscopy).  The 
prototypes were delivered directly to the gastric cavity or endoscopically placed in the small intestine 
through the overtube. Prototypes were followed with serial x-rays. A total of five stomach-deposited 
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characterization devices were evaluated in five separate pig experiments.  One device (C1) was 
retrieved early from the small intestine after recording for 8.3d and passing through the pylorus.  Two 
devices stopped their recording early owing to leakages in the PDMS/epoxy encapsulation: one after 
7.1 days of measurement but prior to reaching the small intestine (C2), and one after 10.1 days of 
measurement, including 8.0 days in the stomach and 2.1 days spent in the small intestine (C4), as 
estimated by the observed power density drop.  Two devices (C3 and C5) recorded all the way to exit 
(8.8d and 7.5d of recording).  The four devices reaching the small intestine exhibited significant power 
density drops co-inciding with extra gastric location.  Three additional characterization devices (C6 to 
C8) were deployed directly into the duodenum to confirm the power density differential, all of which 
recorded from deposition until exit (3.0d, 2.9d, and 2.3d respectively).  Finally, three self-powered 
temperature devices (D1 to D3) were evaluated in three separate pig experiments (6.8d, 6.6d, and 4.7d 
respectively). All three self-powered devices were deployed in the gastric cavity.  Before placing the 
devices, the electrodes were temporarily supplied with 3 V from an external source in order to 
guarantee cold-start of the harvester and to obtain a temperature reading from the room for offline 
calibration of the temperature measurement data.  During and after the experiment, we did not see 
evidence of toxicity from clinical observation. While in place animals were maintained on a liberalized 
diet. 
 
Drug release prototype fabrication.  Drug cavities and the substrate of the release prototype were 
first defined with a conventional carbon dioxide laser engraver (Universal Laser Systems VLS 6.60, 
Engraving Systems LLC) on a 1.5 mm thick poly(methyl methacrylate) (PMMA) board (KJ-35052050, 
McMasterCarr). A 300 nm thick gold layer was deposited on a separate PMMA substrate using an 
electron beam evaporator and a polyvinyl alcohol (PVA) film was adhered to the gold surface. The 
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gold/PVA layer was then peeled off from the substrate and transferred to the delivery device to seal the 
cavity by stamping the device into a thin layer of low viscosity epoxy (EPO-TEK 301-1, Epoxy 
Technology). Here the PVA film acts as a dissolvable temporary support layer to provide mechanical 
rigidity for the 300 nm thin gold film during the transfer process. Methylene blue (M9140, Sigma 
Aldrich) is then added to the reservoir, accessible from the bottom of the device, before it is sealed with 
high viscosity epoxy (20445, Devcon). The relatively high viscosity prevents the infiltration of the 
sealant to the filled cavity. Following curing of the epoxy, the sealed device was put into DI water to 
dissolve the temporary PVA film and subsequently dried in air. An electrical connection was then made 
to the gold layer using conductive epoxy (CW2400, Circuitworks). Finally, all conductive areas except 
the membrane portion of the gold layer covering the drug cavity were insulated with medium-viscosity 
UV-curable epoxy (EPO-TEK OG116-31, Epoxy Technology) and subsequently UV cured. 
 
Demonstration of activated drug release. The release prototype and zinc and copper electrodes 
(preparation as described earlier with 30 mm length and 3 mm width) were submerged in physiologic 
gastric fluid. Gastric fluid was endoscopically extracted from live Yorkshire pigs that were on liquid 
diet two days prior to the procedure. The drug release prototype was connected to a controller board 
described earlier, which harvests and releases the captured energy to the prototype. The demonstration 
proceeded in two phases, (1) a control phase, and (2) the release phase. In the control phase, the 
integrity of the device is first tested submerged in gastric fluid (47 hours in our case), while the 
potential of the gold membrane was maintained at the system ground (0 V relative to the zinc). Upon 
determination of its mechanical integrity, and examining the membrane for leakage, the reservoir along 
with harvesting electrodes were placed in a fresh sample of gastric fluid for the release phase. In this 
phase, the controller was configured to short the reservoir electrode to the system VSTOR to deliver 
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packets of charge at the end of each wake-up interval in order to corrode the electrode. The device 
submerged in gastric fluid was observed through a macroscopic lens, and the electrical profile was 
collected through an oscilloscope. 
 
Data collection: A commercial transceiver evaluation board (SmartRF TrxEB, Texas Instruments) was 
used to receive the 900 MHz FSK packets transmitted from the capsules. For the large animal 
experiments, the board and its antenna were mounted above the steel cage area that housed the animals 
(about 2 m above the ground).  The transceiver board was connected via USB cable to a laptop that 
saved the raw packet information for later offline processing in MATLAB version 2014b 
(MathWorks). 
 
Code availability:  The microcontroller code that was used in this study is available in Figshare with 
the identifier “doi:10.6084/m9.figshare.4451420”46. Certain proprietary code from Microchip Inc. that 
was used in the microcontroller is not publicly available. 
 
Data availability:  The data that support the findings of this study are available in Figshare with the 
identifier “doi:10.6084/m9.figshare.4451420”46. The authors declare that all other data supporting the 
findings of this study are available within the paper and its Supplementary Information. 
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Figure captions 
 
Figure 1 | Initial in vivo characterization and anode comparison. (a) Mg-Cu electrodes for probing 
the available power in vivo in different areas of the stomach and duodenum, with results shown in b, c 
and d. (b) Example of measured electrode voltage and output power density versus load current density 
(2 mm x 2 mm electrodes, duodenum). (c) Measured peak power density (horizontal bars denote 
mean), taken at the peak indicated in b, for different electrode sizes and locations (N = 3). (d) Voltage 
at peak power in c (N = 3),  (e) Electrode configuration for anode comparison in vitro with 
measurements given in f and g. (f) Measured peak power density across time for both anode 
configurations. (g) Summary of the measured performance. 
 
Figure 2 | Electrical characterization of the gastric battery in a porcine model. (a) Simplified 
architecture of the measurement system. (b) Photograph of the front and reverse sides of the system 
along with encapsulation using epoxy and PDMS.  The PCB includes the programmable load resistor 
(DCP), crystal (XTAL), microcontroller (µP), RF matching network (MATCH), and antenna (ANT) on 
the front side, and the battery (BATT) and decoupling capacitor (CAP) on the reverse. (c) Diagram of 
the experimental setup, including photograph of the encapsulated pill in contact with gastric fluid 
inside the porcine stomach.  (d, e, f) In vivo power characterization for a representative device (C4) 
including d: the voltage at the point of maximum power extraction during each sweep frame, e: the 
peak extracted power level in each frame and f: the measured body temperature.   (g) X-rays at two 
time points showing passage from the stomach to the small intestine and the corresponding drop in 
observed power. (h) Statistical summary of the source voltage characterization data for 8 deployed 
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devices (window size, 1h; IQR, interquartile range). (i) Corresponding peak power measurements for 
the 8 devices. 
 
Figure 3 | Demonstration of the gastric cell powering temperature measurement, wireless 
transmission, and drug delivery.  (a) Architecture of the harvesting system. (b) The fabricated and 
encapsulated system printed circuit board. (c) Snapshot of storage capacitor during continuous 
harvesting in SGF. (d) Summary of the in vivo measured performance of three deployed devices in a 
porcine model. (electrode area: 30 mm x 3 mm, thickness: 2 × 250µm). (e) Example of the full in vivo 
measurement data for a representative device (D1), including the estimated average power harvested by 
the board in t = 1 h windows versus time and the overall average power (red line).  (f) In vivo 
measurement of the body temperature performed using the harvested power. (g) Received signal 
strength indication (RSSI) at the receiver for packets transmitted from the body using the harvested 
power. (h) Image of a drug release prototype device, placed on a United States dime (scale bar, 5 mm). 
(i) Cross-sectional view of the device in h, where methylene blue is contained in a PMMA reservoir 
sealed with a 300 nm gold membrane and epoxy. (j) Demonstration of self-powered release (blue tail) 
from the device (yellow box) after activation in a beaker of porcine gastric fluid. Inset shows sequential 
images where the simulated drug is released in gastric fluid through gold corrosion. The gold 
membrane is intact in the beginning (t = 5 min) before triggered corrosion weakens the gold membrane 
causing crack formation on the film at t = 155 min (as shown by blue arrows), and ultimately the 
release of significant amount of methylene blue as shown at 355 min (blue color dye, shown in the red 
arrow). (k) Electrical profile during delivery of a pulse of charge to the release electrode. The dark line 
is the storage capacitor voltage and the lighter line is the voltage on the gold release electrode. 
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Supplementary Figure 4: Measured peak power density (Pmax) and source voltage (obtained at
the peak power, VPmax) for five capsules deposited in the stomach (C1 to C5) and three capsules
deposited in the small intestine (C6 to C8). The sampling rate is one sample every 576 s, and the
data are averaged into bins of size 1 h for display. The dashed lines in C1 to C5 indicate the times at
which x-rays were taken: ‘G’ indicates when the capsule was determined to be in the gastric cavity and
‘I’ indicates the capsule was in the intestine.
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Supplementary Figure 5: Summary of power and voltage levels measured with the
characterization capsule in a porcine model.
5
Device Deposit 
Location 
Electrode  
Length 
 
Time1 
(T) 
Average during T 
Volt. at Peak 
Power 
Peak Power 
(w = 
3mm) [μW/mm
2] 
C1 Stomach 30 mm 5.71 d 0.148 V      0.98 
C2 Stomach 10 mm 7.16 d 0.127 V      1.07 
C3 Stomach 10 mm 3.20 d 0.135 V      1.58 
C4 Stomach 10 mm 7.86 d 0.144 V      0.88 
C5 Stomach 10 mm 0.88 d 0.185 V      1.21 
C6 Small Int. 10 mm 3.01 d 0.102 V      0.0138 
C7 Small Int. 10 mm 2.90 d 0.090 V      0.0121 
C8 Small Int. 10 mm 2.27 d 0.101 V      0.0136 
(C1,C3,C4,C5) Time of passage to the small intestine, estimated as the duration 
after which the measured peak power level remained below 0.20 μW/mm2. 
(C2)  Device malfunctioned before passage to the intestine.  The total available 
measurement duration of 7.16 d is used. 
(C6, C7, C8)   Total measurement duration until the capsule exited the body. 
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Supplementary Figure 6: Connection diagram for the energy harvesting boost-converter IC.
The voltage on the storage capacitor is regulated to 3.3 V, and after startup, the voltage at the input is
regulated to a fixed ratio of the storage capacitor voltage (1/12th). The OK signal turns on and starts
the microcontroller code once the storage capacitor reaches 3.2 V, and turns off if the voltage declines
to below 2.2 V.
Supplementary Figure 7: Energy harvesting demonstration setup. (a) Flow diagram for the
microcontroller code. (b) Illustration of the starting and stopping of the microcontroller code based
on the storage voltage relative the to the hysteresis levels set by the energy harvesting IC. (c)
Measured energy consumption for a packet versus storage voltage level.
a b
Vdd Packet energy
3.0 196.5 µJ
3.1 207.7 µJ
3.2 217.6 µJ
3.3 229.4 µJ
c
6
70
1
OK
0 20 40 60 80 100
0
1
Time [s]
DA
TA
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
V s
to
r[
V]
Startup  Normal  
operation 
Input power  
applied 
Packets 
Supplementary Figure 8: Measured waveforms during bench-top operation (Iin = 400 μA). The
top red trace is the voltage across the storage capacitor. The middle green trace is a digita l signal that
is low during the startup and ensures the microcontroller remains disconnected from the storage
capacitor. The bottom cyan trace is the transmitted data.
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Supplementary Figure 9: Measurements from three harvesting capsules (D1 to D3) deposited in
the stomach of a porcine model. Top plot: average power delivered to the system load, estimated
using the number of transmitted packets. Middle plot: temperature measurement result. Bottom plot:
RF signal strength at the receiver basestation. All data are captured at the variable arrival rate of the
packets (every 12s on average across all three experiments) and averaged into bins of size t = 1 h for
display. (s) Statistical summary of the power availability.
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